| 
                    
                        |
 
                            
                            | 
	
                                  
                                
 |  
                            | 
        
            |   |  
            | 
 
                    
                        | A-911 / A-911-1ML updated item number format 
                                7-Aminoflunitrazepam1.0 mg/mL in Acetonitrile |Certified Reference Material |  
                        | As a major metabolite of flunitrazepam, 7-aminoflunitrazepam is a biomarker for use of the parent drug. Flunitrazepam is an intermediate-acting benzodiazepine, typically used in the treatment of severe insomnia. This certified solution standard is suitable for numerous GC/MS or LC/MS testing applications in forensic analysis, clinical toxicology, urine drug testing, or pain prescription monitoring. |  
                        | 
                                
	|  |  |   |  
	| Concentration: | 1.0 mg/mL |  
	| Solvent: | Acetonitrile |  
	| Unit Size: | 1 mL/ampoule |  
	| CAS Number: | 
                                            34084-50-9 |  
	| Chemical Formula: | 
                                            C16H14FN3O |  
	| Molecular Weight: | 
                                            283.30 |  
	| Certificate of Analysis: |  |  
                                    | US List Price: |  |  |  
                        | 
				***Promotional Pricing Applied in Shopping Cart***
			     
 |  
                        | 
                                
                                    
                                    
                                        
                                        
                                        
                                     
                                        
	
		
			| ▶  Fast and Sensitive  Target Compound  Quantification and  Confirmation with a  New Triple  Quadrupole  Acquisition Function | Michael Flanagan, Agilent Technologies, Inc., 2011 |  
			| ▶  Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples | Robert M. Sears, Toxicology Technical Leader , Kenneth Lewis, CEO , and Kim Gamble, President, ITSP Solutions, INC., 2014 |  
			| ▶  Proof of Concept/Comparison of Automated SPE/HPLC/MS/MS Methods to Traditional Immunoassay with MS Confirmation in Death Investigation Cases | Robert M. Sears, Wendy C. Bell , Kenneth C. Lewis, Thurman L. Allsup and Kim Gamble, ITSP Solutions, INC., 2014 |  
			| ▶  UHPLC/MS/MS Analysis of Benzodiazepines and Glucuronide Metabolites in Urine on Titan™ C18 after SPE using Supel™-Select HLB, ß-Glucuronidase Enzyme Digestion | Sigma-Aldrich®, 2014 |  |  |  
 
 |  
                            
                                     |